Drugs / omega-3 fatty acids (fish oil)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| — | NCT01704859 Comparator | Jun 2018 → Mar 2022 | — | Brigham and Women's Hospital | Completed | No outcome recorded |
| — | NCT01758081 Comparator | Jul 2010 → Dec 2026 expected | infectious disease | Brigham and Women's Hospital | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | omega-3 fatty acids (fish oil) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01758081 ↗ |
| Known as | Omacor | “vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor® fish oil, 1 gram)” NCT01704859 ↗ |